Product details
Catalog number BNUB0895-500
Price for BNUB0895-500
Size / count 1x 500 µL
KBA.62 is a novel anti-melanoma antibody. It reacts positively against melanocytic tumors but not other tumors, thus demonstrating specificity and sensitivity. Moreover, it reacts positively against junctional nevus cells but not intradermal nevi, and against fetal melanocytes but not normal adult melanocytes. KBA.62 antibody is useful in identifying malignant melanomas. Metastatic amelanotic melanoma can often be confused with a variety of poorly differentiated carcinomas, large cell lymphomas, sarcomas, spindle cell carcinomas and various types of mesenchymal neoplasms. A keratin-negative, vimentin-rich neoplasm that immuno-reacts with antibody to S-100 protein and with KBA.62 antibody is, with rare exception, a melanoma. Anti-KBA.62 is a useful additional marker for melanoma, specifically in desmoplastic/spindle cell cases and in the context of micro-metastasis in sentinel lymph node.Primary antibodies are available purified, or with a selection of fluorescent CF® Dyes and other labels. CF® Dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.
The catalog number for Melanoma Marker (KBA.62), 0.2mg/mL is BNUB0895-500.
Melanoma Marker (KBA.62), 0.2mg/mL is available in the following size(s): 1x 500 µL.
Melanoma Marker (KBA.62), 0.2mg/mL is currently made to order / not held in immediate stock. Contact us for lead time.
Melanoma Marker (KBA.62), 0.2mg/mL is manufactured by Biotium.
Estimated delivery time for Melanoma Marker (KBA.62), 0.2mg/mL is approximately 15 business day(s), depending on your location.
The safety data sheet for Melanoma Marker (KBA.62), 0.2mg/mL is available here: https://cdn.gentaur.com/products/37/68dd0299061270361e100f86/msds/bnub0895-500.pdf.
KBA.62 is a novel anti-melanoma antibody. It reacts positively against melanocytic tumors but not other tumors, thus demonstrating specificity and sensitivity. Moreover, it reacts positively against junctional nevus cells but not intradermal nevi, and against fetal melanocytes but not normal adult m
Report this to us immediately with photos and your order reference. Our specialists will assess whether the product is still usable given the cold-chain interruption, and will arrange a replacement or credit if it isn’t.
The host species used in production is listed under product specifications on the datasheet, and is relevant when selecting a compatible secondary antibody for your assay.
Differences typically involve clone, conjugate, host species, or validated applications. Compare the respective datasheets, or contact us with both catalogue numbers for a direct comparison.